What does liposomal do to your body?

Swallow a liposomal supplement and the first thing it has to do is survive your stomach — which is where the interesting part begins.

Liposomes are microscopic spheres of phospholipid built to carry a nutrient past the bottlenecks that limit ordinary absorption. With vitamin C those bottlenecks are real: above 1 gram a day, absorption falls below 50% and the surplus leaves in your urine.

Here is what the evidence says actually happens — in your gut, your blood and your tissues — and where it stops.

Table of Contents

1. What "liposomal" actually means
2. How a liposome gets through your gut wall
3. The bottleneck liposomes are built to get around
4. What shows up in your bloodstream
5. What your body does with the shell
6. Where the vitamin C ends up
7. What is still unknown
8. Bio Absorb Liposomal Vitamin C — delivery you can check
9. Frequently Asked Questions
10. Conclusion
11. Research References

What "liposomal" actually means

A liposome is a sphere whose wall is a phospholipid bilayer — the same two-layer architecture your own cell membranes use. The 2025 scoping review describes vesicles ranging from 20 nanometres to over 1 micrometre, a 50-fold spread that tells you how loosely the category is defined.

The honest answer to what liposomal does to your body starts earlier than most articles admit: it depends on whether the product contains liposomes. The UK's Committee on Toxicity records substantial uncertainty about the identity of enhanced-bioavailability supplements on sale, noting that absorption claims are frequently made without a reference or a stated comparison.

Independent analyses cited in that review found one product with no detectable liposomes and another containing roughly 4% of its claimed vitamin C. One of them prompted an Advertising Standards Authority investigation into a product marketed as liposomal vitamin C, which ended in a ruling against the advert. The Committee is careful to add that those analyses came from competing companies and were never published in full — so treat them as a reason to ask for testing data, not as a verdict on the category.

How a liposome gets through your gut wall

Ordinary vitamin C is ferried across your intestinal lining by a protein called SVCT1. A liposome does not need it. Research on oral liposome delivery finds that the transcellular route is the main way liposomes cross the intestinal epithelium, by one of two mechanisms.

In membrane fusion, the liposome's bilayer merges with the cell membrane and releases its contents inside. In endocytosis, the cell engulfs the vesicle whole. Clathrin-mediated endocytosis is thought to do much of the work in the gut, because enterocytes express clathrin-associated proteins heavily. Liposomes also show an inherent affinity for lymphatic tissue, which offers a second route into circulation.

Two practical consequences follow. The first is that uptake is not capped by a single saturable transporter. The second is that the 2025 review found no clear dose-to-concentration relationship across 10 trials spanning doses from 0.15 to 10 grams — the mechanism is real, but it does not scale predictably.

The bottleneck liposomes are built to get around

Your body regulates vitamin C tightly, and most of that control sits at the gut wall. The absorbed fraction falls as the dose climbs, because SVCT1 expression drops in response:

• 87% absorbed at 30 mg
• 80% at 100 mg
• 72% at 200 mg
• 63% at 500 mg
• Under 50% at 1,250 mg

There is a ceiling on the other side too. The same review puts it at roughly 220 micromoles per litre once daily doses pass 500 mg, and the kidneys clear the rest. The NIH describes the result plainly: oral vitamin C produces concentrations the body tightly controls, with unmetabolised ascorbic acid excreted in urine.

This is the problem liposomal delivery is designed for, and it is the reason the format exists at all. Our complete guide to liposomal vitamin C covers the saturation curve in more detail, and our article on why most of your vitamin C dose is wasted works through the transporter itself.

What shows up in your bloodstream

The most complete assessment is a 2025 scoping review in Basic & Clinical Pharmacology & Toxicology, which screened 321 studies and included 10 that compared the two forms head to head. Nine of the 10 reported higher plasma bioavailability for the liposomal form, with peak concentrations 1.2–5.4 times higher and total exposure 1.3–7.2 times higher.

That range is wide for a reason. A 2024 double-blind crossover trial in 27 adults given a single 500 mg dose found peak levels about 27% higher and 24-hour exposure about 21% higher — real, but at the modest end. Results vary with the formulation, the dose, the sampling window and how depleted the person was to begin with.

The honest caveat sits in the same review. Only two of the 10 trials looked at whether any of this changes a biological outcome. In the one with a 1.4-fold difference in exposure, both forms gave comparable protection against lipid oxidation. Higher blood levels are established. Better health outcomes are not. Our article on liposomal versus regular vitamin C works through that distinction.

What your body does with the shell

The liposome wall is phosphatidylcholine, usually from sunflower or soy lecithin. Once the vesicle has delivered its cargo, that material is digested like any other dietary phospholipid — phosphatidylcholine is a normal component of your cell membranes and a major dietary source of choline, for which the Adequate Intake in adult men is 550 mg a day.

Choline supplements raise a reasonable question, because gut bacteria can convert choline into TMAO, a metabolite linked with cardiovascular risk. The form appears to matter. In a randomised trial with five arms over four weeks, choline bitartrate raised plasma TMAO and platelet reactivity in all three arms containing it, while phosphatidylcholine supplements did not raise TMAO (p=0.27) or platelet reactivity (p=0.79).

A separate randomised crossover in six healthy men found the same pattern by a different method: every water-soluble choline form raised TMAO quickly, while egg phosphatidylcholine did not. Both trials are small, and neither tested liposomal vitamin C specifically — but on the available evidence the shell behaves like food, not like a free choline supplement.

Where the vitamin C ends up

Getting more into your blood is not the same as getting more into your cells, and your body decides the second part. A different transporter, SVCT2, handles uptake into metabolically active tissue, and it has roughly 12 times the affinity of SVCT1 — a Km of 21.3 micromoles per litre against 252.

The practical effect is a priority system. Vitamin C sits at micromolar concentrations in plasma but millimolar concentrations in tissue, with distribution governed by SVCT2 expression and renal reabsorption swinging anywhere from 0 to 100% depending on how saturated you already are.

Which is why total body content stays in a narrow band. The NIH puts total body content at 300 mg near scurvy and about 2 grams when replete. If you are already near the top of that range, better absorption mostly means a busier set of kidneys. If you are not, it means the gap closes faster. The 2025 review found that baseline vitamin C status was one of the factors driving the variation between trials.

What is still unknown

The 2025 review was written to identify gaps, and it names three. None of the 10 trials measured how much ascorbate was subsequently excreted. Only two looked at cellular uptake. Only two looked at any biological effect at all.

Regulators are asking a related question. The UK Committee on Toxicity's 2025 report recommends that novel formulations be assessed for toxicokinetics case by case, since a format that raises absorption may shift the dose-response relationship that existing safety limits were built on. The Committee also flags that whether you take it with food is a key determinant of bioavailability.

That is not a reason for alarm, but it is a reason for restraint. The 2,000 mg daily tolerable upper intake level still applies, and it covers food, drink and supplements together. If you have kidney disease, haemochromatosis or any iron-overload condition, or you take regular medication, talk to your doctor before adding a vitamin C supplement in any format.

Bio Absorb Liposomal Vitamin C — delivery you can check

Given that regulators have flagged how variable the liposomal market is, the sensible thing to ask any brand for is evidence rather than adjectives.

Bio Absorb Nutraceuticals makes Liposomal Vitamin C in two formats. The liquid mixes with water or juice; the capsules need no refrigeration and travel well. Both are verified corn-free, non-GMO, gluten-free, nut-free, dairy-free and vegan — which matters more than usual here, because the shell material in a liposomal product is itself an ingredient worth knowing the source of.

Everything is made in a GMP-certified Canadian facility, Health Canada–approved, with every batch independently third-party tested and a certificate of analysis available on request. That last point is the one to hold brands to. A company that will send you batch testing data is answering the question the Committee on Toxicity raised; one that only repeats absorption claims is not.

If you are deciding between the two formats, the choice is practical rather than pharmacological — whether you would rather measure a liquid or swallow a capsule. Both carry the same money-back guarantee, so the decision is reversible. See current pricing and serving details for the liquid, or the full specification for the capsules.

Frequently Asked Questions

Does liposomal vitamin C bypass the liver?

Partly, and the evidence is indirect. Liposomes show an affinity for lymphatic tissue, which avoids first-pass hepatic metabolism, but the main documented route is transcellular transport through the intestinal cells rather than lymphatic uptake.

Is the liposome shell safe to take every day?

Phosphatidylcholine is a normal part of the human diet and of your own cell membranes. In a four-week randomised trial it did not raise TMAO or platelet reactivity, unlike free choline supplements, though the phosphatidylcholine arm had only 10 participants.

Can I take more vitamin C because it is liposomal?

No — the 2,000 mg daily upper limit applies to all forms and all sources combined. If anything, a format that raises absorption is a reason to be more careful with the total, not less.

How can I tell if a product really contains liposomes?

You largely cannot, from the label alone. UK regulators found wide variation in particle size between products sold as liposomal, so the practical test is whether the brand will provide third-party batch testing on request. Our guide to how to choose a liposomal vitamin C supplement goes through the rest of the checks.

Does better absorption mean better health outcomes?

Not established. Of 10 trials in the 2025 review, only two measured a biological effect, and the one that compared protection against lipid oxidation found the two forms comparable despite a 1.4-fold difference in blood exposure.

Should I take it with food?

Possibly, though the data is thin. The UK Committee on Toxicity names fed versus fasted state as a key determinant of bioavailability for novel formulations, and says it must be accounted for when comparing them.

Conclusion

What liposomal does to your body is narrower than the marketing suggests and better evidenced than the sceptics allow: it gets more vitamin C past a transporter that otherwise absorbs under 50% of a 1,250 mg dose, with 9 of 10 trials showing higher blood levels. Whether that changes anything you would feel has not been shown. If you want the format, pick a brand that will show you its testing — see the current details for Bio Absorb Liposomal Vitamin C.

Research References

1. Do Liposomal Vitamin C Formulations Have Improved Bioavailability? A Scoping Review Identifying Future Research Directions. Basic & Clinical Pharmacology & Toxicology, Vol. 137, Issue 1, e70067 (2025). Identified 10 trials comparing liposomal with non-liposomal ascorbate at doses of 0.15 to 10 g. Nine reported higher plasma bioavailability, with peak concentrations 1.2–5.4 times higher and total exposure 1.3–7.2 times higher.
2. Liposomal delivery enhances absorption of vitamin C into plasma and leukocytes: a double-blind, placebo-controlled, randomized trial. European Journal of Nutrition, Vol. 63, Issue 8, pp. 3037–3046 (2024). Double-blind crossover trial in 27 adults given a single 500 mg dose. The liposomal form raised peak plasma concentration by about 27% and 24-hour exposure by about 21%.
3. Liposomal-encapsulated Ascorbic Acid: Influence on Vitamin C Bioavailability and Capacity to Protect Against Ischemia–Reperfusion Injury. Nutrition and Metabolic Insights, Vol. 9, pp. 25–30 (2016). Gave 11 adults 4 g of vitamin C by several routes. The liposomal form produced a 1.4-fold higher plasma AUC, yet both forms gave comparable protection against lipid oxidation after forearm ischemia.
4. Vitamin C in Health and Disease: Its Role in the Metabolism of Cells and Redox State in the Brain. Frontiers in Physiology, Vol. 6, Article 397 (2015). Sets out the two sodium-dependent vitamin C transporters. SVCT2 has an apparent Km of 21.3 µmol/L against 252.0 µmol/L for SVCT1, giving it roughly 12 times the affinity.
5. The Role of Vitamin C in Cancer Prevention and Therapy: A Literature Review. Antioxidants, Vol. 10, Issue 12, Article 1894 (2021). Reports that intestinal absorption falls as SVCT1 expression drops — 87% at 30 mg, 80% at 100 mg, 72% at 200 mg, 63% at 500 mg and under 50% at 1,250 mg — with plasma peaking near 220 µmol/L above 500 mg a day.
6. On the effect of vitamin C intake on human health: How to (mis)interprete the clinical evidence. Redox Biology, Vol. 34, Article 101532 (2020). Describes vitamin C distribution as governed by SVCT2 expression and tissue priority, with active renal reabsorption ranging from 0 to 100% depending on how saturated the body already is.
7. Liposomes in oral delivery: mechanisms, advances, challenges, and future perspectives. Journal of Liposome Research, published online ahead of print 3 June 2026, pp. 1–21 [volume and issue not yet assigned]. Reviews the mechanisms by which liposomes cross the intestinal epithelium, covering transcytosis, paracellular transport and lymphatic uptake.
8. Dietary Choline Supplements, but Not Eggs, Raise Fasting TMAO Levels in Participants with Normal Renal Function: A Randomized Clinical Trial. The American Journal of Medicine, Vol. 134, Issue 9, pp. 1160–1169.e3 (2021). Five-arm, four-week randomised trial. Choline bitartrate raised plasma TMAO and platelet reactivity in all three arms containing it; phosphatidylcholine supplements raised neither (P=0.27 and P=0.79) in an arm of 10 participants.
9. Differential metabolism of choline supplements in adult volunteers. European Journal of Nutrition, Vol. 61, Issue 1, pp. 219–230 (2022). Randomised crossover in six healthy men. Every water-soluble choline supplement raised TMAO rapidly while egg phosphatidylcholine did not. Gives the NAM adequate intake for adult men as 550 mg a day.
10. Vitamin C — Fact Sheet for Health Professionals. National Institutes of Health, Office of Dietary Supplements (updated 31 July 2025). Sets the 2,000 mg adult tolerable upper intake level, records that absorption falls below 50% above 1 g a day, and puts total body content between 300 mg near scurvy and about 2 g when replete.
11. Novel formulations of supplement compounds designed to increase oral bioavailability. Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment (2025). Recommends that novel high-bioavailability formulations be assessed for toxicokinetics case by case, and names fed versus fasted state as a key determinant of bioavailability.
12. Novel formulations of supplement compounds — Annex A: Uncertainties surrounding novel supplement formulations. Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment (2025). Records wide variation in particle size between products sold as liposomal, one product with no detectable liposomes and another containing about 4% of its claimed vitamin C, and notes that those analyses came from competing companies and were never published in full.

About the Author

David Kimbell is a health writer, digital entrepreneur and former aerospace engineer, based in Ottawa, Canada. He loves translating complex science into clear, actionable guidance for consumers seeking evidence-based solutions.

---

Important Disclaimers

Medical Disclaimer: This article provides educational information only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing.

FDA/Health Canada Statement: These statements have not been evaluated by the Food and Drug Administration or Health Canada. This product is not intended to diagnose, treat, cure, or prevent any disease.